Speech-Language Pathologists in Greenville, KY Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Miss Erynn Deann Leis, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 515 Greene Dr, Greenville, KY 42345 Phone: 270-338-5400    Fax: 270-338-2336

Mr. Douglas Alan Brandow, M.S./CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 515 Greene Dr, Greenville, KY 42345 Phone: 270-338-0507

Felicia Wells Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 515 Greene Drive, Greenville, KY 42345 Phone: 270-338-5400    Fax: 270-338-2336

Mrs. Leslie Handley, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 521 Greene Dr, Greenville, KY 42345 Phone: 270-338-1523

Mrs. Paige Burch, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Chestnut St, Greenville, KY 42345 Phone: 270-617-4093

News Archive

Two new analyses raise questions about mortality rate of bird flu

In an analysis published Thursday in the online edition of the journal Science, a team led by virologist Peter Palese of Mount Sinai School of Medicine in New York argue the mortality rate from H5N1 bird flu is under one percent, much lower than the WHO's estimated fatality rate of 59 percent, Reuters reports.

Heart failure patients have higher risk of death than people with common cancers

A study led by Keele University, in collaboration with the Universities of Aberdeen and Manchester, shows that men and women suffering from heart failure have a higher risk of death than people with most common types of cancer.

HIIT helps achieve critical health outcomes for individuals with Down syndrome

Incorporating high-intensity interval training, or HIIT, into exercise programs for individuals with Down syndrome may help achieve critical health outcomes in a more time-efficient manner, according to an article written by researchers at the University of Georgia and Kennesaw State University.

FDA approves Gilead's Complera for treatment of HIV-1 infection

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Complera, a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.

Direct contact with lymphatic endothelial cells promotes melanoma metastasis

Despite the declining death rates for many individual cancer types, mortality for a few cancers has stabilized or even increased. One of these is melanoma due to its ability, in later stages, to spread to other parts of the body.

Read more Medical News

› Verified 7 days ago